Press Release Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target Sep 17
Press Release Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto Sep 15